Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer families
✍ Scribed by Phelan, Catherine M.; Lancaster, Johnathan M.; Tonin, Patricia; Gumbs, Curtis; Cochran, Charles; Carter, Ron; Ghadirian, Parviz; Perret, Chantal; Moslehi, Roxana; Dion, France
- Book ID
- 109916003
- Publisher
- Nature Publishing Group
- Year
- 1996
- Tongue
- English
- Weight
- 435 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1061-4036
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Family history is a well-recognized risk factor for the development of breast cancer. The isolation of BRCA1 and BRCA2 genes, the two major predisposing genes in familial and to early onset breast and ovarian cancer, has resulted to the identification of a large number of families with mutations in
Sixty high-risk breast and/or ovarian cancer families from North-Eastern Poland were screened for germline mutations in BRCA1 (MIM# 113705) and BRCA2 (MIM# 600185), using a combination of protein truncation test, denaturing high-performance liquid chromatography and direct sequencing. Sixteen (27%)
Duchenne muscular dystrophy (DMD) is an X-linked degenerative disorder of muscle, caused by gross rearrangements by the dystrophin gene in two-thirds of cases. The remaining one-third of patients may carry more subtle mutations that are difficult to detect because of the large size and complexity of